NewslettersEndothelial Cell NewsUncategorizedBevacizumab Attenuates Osteosarcoma Angiogenesis by Suppressing MIAT Encapsulated by Serum-Derived Extracellular Vesicles and Facilitating miR-613-Mediated GPR158 InhibitionBy Justin.choi - March 28, 2022041Scientists investigated the therapeutic potential of bevacizumab in angiogenesis during osteosarcoma and the related mechanisms.[Cell Death & Disease] 6445212 BBBBBBBB items 1 apa 0 default asc 1 173311 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Full Article